Nudges for Statin Prescribing in Primary Care

University of Pennsylvania4,131 enrolled

Overview

The objective of the study is to evaluate the effect of nudges to clinicians, patients, or both to initiate statin prescriptions for patients that meet national guidelines.

Cardiovascular disease (CVD) is the leading cause of mortality in the United States. Statins have been demonstrated to be an effective tool for reducing the risk of CVD-related events and mortality, but statins are often not prescribed for patients that meet evidence-based guidelines. In this study, the investigators will evaluate nudges to clinicians, patients, or both to initiate statin prescriptions for patients that meet the United States Preventive Task Force guidelines, patients with clinical atherosclerotic cardiovascular disease (ASCVD) condition, and patients with a history of familial hyperlipidemia. In partnership with the health system, this will be conducted as a 4-arm factorial, cluster randomized trial to evaluate the effect of the interventions.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

DOUBLE

Enrollment

4,131

Conditions

Cardiovascular Diseases

Interventions

Clinician NudgeBEHAVIORAL

Active choice intervention in the electronic health record and peer comparison messaging on performance

Patient NudgeBEHAVIORAL

Text message sent to patients to prompt awareness of statin eligibility before an appointment with their primary care physician

Eligibility

Sex: ALLMin age: 21 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Have new or return visit with a primary care provider at one of the study practices at the University of Pennsylvania Health System 2. Either have an ASCVD condition, history of familial hyperlipidemia, or meet United State Preventive Task Force Guidelines for Statin Therapy which includes age 40-75 years, at least 1 cardiovascular risk factor (e.g. dyslipidemia, diabetes, hypertension, smoking), 10-year ASVCD risk score ≥ 10% Exclusion Criteria: 1. Already prescribed a statin 2. Allergy to statins 3. Severe renal insufficiency defined as glomerular filtration rate (GFR) less than 30 mL/min or on dialysis 4. Adverse reaction to statins including statin-related a) myopathy; b) Rhabdomyolysis; c) hepatitis 5. Pregnant 6. Currently breastfeeding 7. on hospice or at the end-of-life 8. On a PCSK9 Inhibitor medication Clinicians (and their respective patients) will be excluded if they have less than 10 patients among their entire panel that are eligible for a statin medication.

Locations (1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Outcomes

Primary Outcomes

Statin Prescribing

Change in percent of patients prescribed a statin medication.

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.